- About Us
- Who We Serve
- Our Tissues & Products
- Contact Us
Each year MTF Biologics awards major grants to applicants selected through a peer review process and provides financial assistance to on-going research projects. Scientific grants are awarded to researchers at accredited institutions in support of the advancement of allograft transplantation.
For questions regarding the MTF Biologics Grant Program, please contact Jeffrey Cartmell, Ph.D., Director, Intellectual Property and Grants, at email@example.com or (732) 661-2151. For questions of an administrative nature, please contact Christine Jenkins at firstname.lastname@example.org or (732) 661-2159.
MTF Biologics offers research grants to fund novel research in the fields of allograft transplantation and allograft science which have a high likelihood of impact on scientific discipline and/or on patient care.
These grants are intended to provide support for research projects focused on novel uses of allografts or allograft-derived materials for biologic repair and reconstruction with a strong clinical translation component in the following areas: Orthopedics, Spine, Sports Medicine, Wound Care, the use of Adipose and Placental tissues, or other novel allograft transplant technologies.
Proposed studies should focus on innovative translational and clinical research in the fields of tissue allograft transplantation and science, novel uses of allografts, combination with other biomaterials to enhance properties, and transformative regenerative medicine technologies relying on allograft tissues and matrices.
MTF Biologics considers both clinical science and basic science proposals for funding in the following grant categories. The application deadline for all grants was March 1, 2020.
For 2020, all grant applications must be submitted via the MTF Biologics Grant Application form below. Interested applicants should download the Grant Application below and upload the completed application with your form submission.
The submission deadline for the MTF Biologics Administered Grant applications was March 1, 2020.